Recently validated on pseudomonas and TB samples, the business card-sized device also enables on-chip extraction.
The test analyzes the mitochondrial genome to determine which men with clinical suspicion of prostate cancer are likely to have high-grade disease.
The study compared five methods, including three based on Roche test kits and reagents, and suggested that a multiplexed test may be best to avoid false-negative results.
The tests are twice as fast as the firm's Xpert line and run on Cepheid's flagship GeneXpert system.
The preliminary revenue results come ahead of the company's planned merger with Takara Bio USA Holdings.
In Science this week: intellectual property landscape of CRISPR genome editing, and more.
A researcher has been convicted of conspiring to steal genetically engineered rice, Reuters reports.
Harvard Medical School's George Church says a woolly mammoth-elephant hybrid is only a few years away, according to the New Scientist.
Intel is ending its sponsorship of the International Science and Engineering Fair, the New York Times reports.
This online seminar will highlight recent advances in the use of next-generation sequencing to detect drug-resistant mutations in patients with HIV or HCV.
This webinar will discuss how next-generation sequencing and digital PCR can be used in a complementary manner for liquid biopsies in order to improve patient care.